In an article titled “Hybrid revascularization remains relatively rare bird” (published March 6, 2015) Dr. Vinod H. Thourani wishes to clarify that, as he stated in his presentation, the current work he reported on from Emory University was performed by Dr. Michael Halkos, who is the leader of hybrid revascularization at Emory, and that Dr. Halkos was lead author and researcher in several of the other studies reported upon.

Ads

You May Also Like

FDA approves nivolumab for advanced urothelial carcinoma

The Food and Drug Administration has granted accelerated approval to nivolumab for treatment of ...

Menopause accelerates RA functional decline

FROM RHEUMATOLOGY Rheumatoid arthritis gets worse after menopause, likely because of lower hormone levels, ...